Treatment News : Potential Microbicide Tricks HIV Into Sudden Death

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » October 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

October 10, 2013

Potential Microbicide Tricks HIV Into Sudden Death

Joining the crop of investigational anti-HIV agents that attack the virus before it can enter immune cells, a new potential microbicide element tricks HIV into expelling its DNA before latching onto a human cell, thus prompting a benign death. Publishing their findings in Antimicrobial Agents and Chemotherapy, researchers at Drexel University engineered a molecule from segments of other molecules in order to create a dual action virolytic entry inhibitor, or DAVEI.

In order for HIV to infect a human immune cell, it must first fuse to the outside of the cell before inserting its genetic code. The scientists set out to create a molecule that would create a facsimile of this process. One segment of the molecule, known as the membrane proximal external region, is a portion of cellular fusion machinery and has a propensity to interact powerfully with the membranes of the virus. A second segment of the DAVEI is a cyanovirin, which connects to the sugar coating over the spikes on HIV’s surface that the virus uses to attach to human cells.

“For lack of a better term, DAVEI tricks the virus into thinking it is about to infect a healthy cell, when, in fact, there is nothing there for it to infect,” Cameron Abrams, PhD, a professor in Drexel’s College of Engineering and the study’s principal investigator, said in a statement. “Instead, it releases its genetic payload harmlessly and dies.”

To read the Vaccine News Daily story, click here.

To read a release on the study, click here.

To read the study abstract, click here.

Search: HIV, dual action virolytic entry inhibitor, DAVEI, Drexel University, microbicide, cyanovirin, membrane proximal external region, Cameron Adams.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (2 total)

 
[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Starting Treatment
Search for the Cure
POZ Stories
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar


    dlw8585
    Fort Lauderdale
    Florida


    Poz_Qt
    Columbus
    Ohio


    usuallyhappy
    Palm Springs
    California


    jacob2608
    Panama City Beach
    Florida
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Can social media help stop HIV stigma?
Yes
No

Survey
Mind Matters

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.